Submit Content
Get the latest delivered to your inbox
Privacy Policy

ViiV Healthcare

We are ViiV Healthcare - a global specialist HIV company established by GlaxoSmithKline and Pfizer to deliver advances in treatment and care for people living with HIV. Our aim is to take a deeper and broader interest in HIV/AIDS than any company has done before and then take a new approach to deliver effective and new HIV medicines as well as support communities affected by HIV.

ViiV Healthcare Awards $1 Million in Grants for Positive Action for Women in the U.S. Image

POSTED 

09-05-17

ViiV Healthcare Awards $1 Million in Grants for Positive Action for Women in the U.S.

ViiV Healthcare announced $1 million in grants for Positive Action for Women (PAFW), a pilot initiative that supports innovative, forward-thinking community collaborations that break down...

ViiV Healthcare Expands U.S. Commitment to Youth Living With HIV Through Its Positive Action Program  Image

POSTED 

08-10-17

ViiV Healthcare Expands U.S. Commitment to Youth Living With HIV Through Its Positive Action Program

ViiV Healthcare announced today it will award six new grants designed to help improve the lives of young people living with HIV through its Positive Action for Youth program. The program, which builds on ViiV Healthcare’s ongoing youth-focused programming and outreach, is a two-year, $1 ...

ViiV Healthcare étend son accord de brevets pour le dolutégravir auMedicines Patent Pool (MPP),  de facon acouvrir tous les pays de la tranche inférieure des revenus intermédiaires.  Image

POSTED 

04-25-16

ViiV Healthcare étend son accord de brevets pour le dolutégravir auMedicines Patent Pool (MPP), de facon acouvrir tous les pays de la tranche inférieure des revenus intermédiaires.

ViiV Healthcare, société mondiale spécialisée dans le traitement du VIH, controÌ‚lée par GSK, et comptant Pfizer Inc. et Shionogi Limited parmi ses actionnaires, a annoncé aujourd'hui son intention d’étendre la portée mondiale de son accord de licences nationales concernant ...

ViiV Healthcare Extends Medicines Patent Pool Licence Agreement for Dolutegravir to Cover All Lower Middle-Income Countries Image

POSTED 

04-25-16

ViiV Healthcare Extends Medicines Patent Pool Licence Agreement for Dolutegravir to Cover All Lower Middle-Income Countries

ViiV Healthcare, a global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, today announced an extension of overall country coverage of its existing licence agreement for adults formulation of dolutegravir to the Medicines Patent Pool (MPP) to co...

ViiV Healthcare Awards Additional Round of Grants to Support Innovative HIV Programs Aimed at Reducing Disparities in the Southern U.S. Image

POSTED 

11-20-15

ViiV Healthcare Awards Additional Round of Grants to Support Innovative HIV Programs Aimed at Reducing Disparities in the Southern U.S.

ViiV Healthcare today announced it will award seven grants to organizations across the Southern U.S., a community disproportionately impacted by HIV, as part of its

ViiV Healthcare Awards Innovative Grants for HIV Programs Focused on MSM Youth Image

POSTED 

11-02-15

ViiV Healthcare Awards Innovative Grants for HIV Programs Focused on MSM Youth

ViiV Healthcare today announced it will award grants to five organizations across the country as part of the Positive Action MSM Youth Engagement Initiative. These grants focus on youth-led social and digital communications solutions to help increase sexual health knowledge, reduce stigma and lin...

ViiV Healthcare Launches New Global Positive Action Programme Focused on MSM and Transgender Populations Image

POSTED 

03-31-15

ViiV Healthcare Launches New Global Positive Action Programme Focused on MSM and Transgender Populations

ViiV Healthcare today announced the launch of a new initiative designed to support and inform the global effort to alleviate the impact of HIV and AIDS among men who have sex with men (MSM) and transgender populations around the world. Through Positive Action, ViiV Healthcare has committed to inv...

ViiV Healthcare Announces $10 Million Initiative to Accelerate Response to HIV/AIDS Among Black Gay and Bisexual Men  Image

POSTED 

02-04-15

ViiV Healthcare Announces $10 Million Initiative to Accelerate Response to HIV/AIDS Among Black Gay and Bisexual Men

ViiV Healthcare today announced the launch of a four-year, $10 million initial investment to fuel a concerted community response to the HIV epidemic among Black Men who have Sex with Men (MSM) in Baltimore, Maryland and Jackson, Mississippi, two U.S. cities hard hit by HIV/AIDS. The goal for this...

ViiV Healthcare announces new grants in support of ending mother to child transmission of HIV Image

POSTED 

11-27-14

ViiV Healthcare announces new grants in support of ending mother to child transmission of HIV

The Positive Action for Children Fund (PACF) is proud to announce 103 grants for 2015 totalling £5 million. 54 new grants and 49 extensions will be funded to support community responses to help end mother to child transmission of HIV thereby delivering crucial services to mothers, chil...

ViiV Healthcare Announces New Initiatives to Improve Access to Dolutegravir: Licence to the Medicines Patent Pool Image

POSTED 

04-01-14

ViiV Healthcare Announces New Initiatives to Improve Access to Dolutegravir: Licence to the Medicines Patent Pool

ViiV Healthcare today announced new collaborations with the goal of increasing access to its HIV medicine, dolutegravir (marketed under the name Tivicay®), just two months after its approval by the European Medicines Agency (EMA) and eight months after approval by the US Food and Drug Administrat...

ViiV Healthcare logo

ViiV Healthcare

ViiV Healthcare

Join today and get the latest delivered to your inbox